The mechanism of EGCG+HC may be through the downregulation of SEMA3A and SEMA3F transcript expression which may play some roles in inhibiting the glioma proliferation and halts invasion via Plexin A1 (PLXNA1) and B2 (PLXNB2) receptors. This evidence concerns the gene SEMA3A and central nervous system cancer.